Brain metabolism of exogenous pyruvate
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Pyruvate given in large doses may be neuroprotective in stroke, but it is not known to what degree the brain metabolizes pyruvate. Intravenous injection of [3‐13 C]pyruvate led to dose‐dependent labelling of cerebral metabolites so that at 5 min after injection of 18 mmoles [3‐13 C]pyruvate/kg (2 g sodium pyruvate/kg), approximately 20% of brain glutamate and GABA were labelled, as could be detected by 13 C nuclear magnetic resonance spectrometry ex vivo. Pyruvate, 9 mmoles/kg, was equivalent to glucose, 9 mmoles/kg, as a substrate for cerebral tricarboxylic acid (TCA) cycle activity. Inhibition of the glial TCA cycle with fluoroacetate did not affect formation of [4‐13 C]glutamate or [2‐13 C]GABA from [3‐13 C]pyruvate, but reduced formation of [4‐13 C]glutamine by 50%, indicating predominantly neuronal metabolism of exogenous pyruvate. Extensive formation of [3‐13 C]lactate from [2‐13 C]pyruvate demonstrated reversible carboxylation of pyruvate to malate and equilibration with fumarate, presumably in neurones, but anaplerotic formation of TCA cycle intermediates from exogenous pyruvate could not be detected. Too rapid injection of large amounts of pyruvate led to seizure activity, respiratory arrest and death. We conclude that exogenous pyruvate is an excellent energy substrate for neurones in vivo, but that care must be taken to avoid the seizure‐inducing effect of pyruvate given in large doses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824 · cited 1×
“It has been shown that hyperglycemia may be detrimental in stroke patients (Kiers et al. 1992; Capes et al. 2001); therefore, administration of glucose may have adverse effects in the acute phase of cerebral ischemia.”
BackgroundNguyen, N. H. T., Bråthe, A., & Hassel, B. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01762.x · Cited by 95
Self-citation
Cited by
In vivo evidence for a lactate gradient from astrocytes to neurons
Mächler, P., Wyss, M. T., Elsayed, M., Stobart, J., Gutierrez, R., von Faber-Castell, A., Kaelin, V., Zuend, M., San Martín, A., Romero-Gómez, I., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.10.010 · Cited by 571
“Upon repeated i.v. injections of pyruvate, neuronal Laconic signal kept increasing, possibly due to the conversion of pyruvate to lactate (Gonzalez et al., 2005).”
BackgroundRae, C. D. (2014) · Neurochemical Research · doi:10.1007/s11064-013-1199-5 · Cited by 496
Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages
Neth, B. J., & Craft, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00345 · Cited by 272
Consumption and Metabolism of Extracellular Pyruvate by Cultured Rat Brain Astrocytes
Denker, N., Harders, A. R., Arend, C., & Dringen, R. (2023) · Neurochemical Research · doi:10.1007/s11064-022-03831-6 · Cited by 22
“However, in addition to glucose, a variety of other extracellular substrates, including lactate, pyruvate, alanine, bHB and acetate, have been reported to be metabolized by astrocytes, at least in culture, and can be used as source for energy production and/or synthesis of other metabolites [4, 13, 14, 52].”
BackgroundExerkines, Nutrition, and Systemic Metabolism
Watkins, B. A., Smith, B. J., Volpe, S. L., & Shen, C.-L. (2024) · Nutrients · doi:10.3390/nu16030410 · Cited by 18
Metadata
- Authors
- Gonzalez, S. V., Nguyen, N. H. T., Rise, F., & Hassel, B.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2005-08-25
- Volume
- 95
- Issue
- 1
- Pages
- 284-293
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1940920393
- Cited by
- 74
- References
- 2
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.